The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease
- PMID: 19579173
The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease
Abstract
This review discusses current knowledge of the complex interactions between amyloid-beta (A beta) peptide, the receptor for advanced glycation endproducts (RAGE), and inflammatory mediators, focusing on the roles of such interactions in the pathogenesis of Alzheimer's disease. As a ubiquitous cell-surface receptor, RAGE demonstrates enhanced expression in an A beta-rich environment; the effects of RAGE on microglia, the blood-brain barrier and neurons are mediated through various signaling pathways. Relevant preclinical models illustrate that the A beta-RAGE interaction amplifies neuronal stress and the accumulation of A beta, impairs memory and learning, and exaggerates neuroinflammation. These findings suggest that RAGE may mediate a common proinflammatory pathway in neurodegenerative disorders.
Similar articles
-
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.Nature. 1996 Aug 22;382(6593):685-91. doi: 10.1038/382685a0. Nature. 1996. PMID: 8751438
-
Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.Exp Neurol. 2001 Sep;171(1):29-45. doi: 10.1006/exnr.2001.7732. Exp Neurol. 2001. PMID: 11520119
-
RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.Acta Neuropathol. 2006 Oct;112(4):405-15. doi: 10.1007/s00401-006-0115-3. Epub 2006 Jul 25. Acta Neuropathol. 2006. PMID: 16865397
-
Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.Neurobiol Aging. 2011 May;32(5):763-77. doi: 10.1016/j.neurobiolaging.2009.04.016. Epub 2009 May 22. Neurobiol Aging. 2011. PMID: 19464758 Review.
-
RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's disease.Curr Mol Med. 2007 Dec;7(8):735-42. doi: 10.2174/156652407783220741. Curr Mol Med. 2007. PMID: 18331231 Review.
Cited by
-
Mechanisms of islet amyloidosis toxicity in type 2 diabetes.FEBS Lett. 2013 Apr 17;587(8):1119-27. doi: 10.1016/j.febslet.2013.01.017. Epub 2013 Jan 18. FEBS Lett. 2013. PMID: 23337872 Free PMC article. Review.
-
S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2496-507. doi: 10.1161/ATVBAHA.115.302072. Epub 2015 Oct 29. Arterioscler Thromb Vasc Biol. 2015. PMID: 26515415 Free PMC article. Review.
-
Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice.Front Cell Neurosci. 2016 May 9;10:117. doi: 10.3389/fncel.2016.00117. eCollection 2016. Front Cell Neurosci. 2016. PMID: 27242430 Free PMC article.
-
The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.Circ Res. 2010 Mar 19;106(5):842-53. doi: 10.1161/CIRCRESAHA.109.212217. Circ Res. 2010. PMID: 20299674 Free PMC article. Review.
-
S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages.Clin Cancer Res. 2013 Jul 15;19(14):3764-75. doi: 10.1158/1078-0432.CCR-12-3725. Epub 2013 May 29. Clin Cancer Res. 2013. PMID: 23719262 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials